Vertex Commits To Novel Reimbursement Plan For Orkambi In UK, Despite Setback
Despite an initial rejection from NHS England, Vertex remains committed to bringing its novel reimbursement plan to England to secure access to its cystic fibrosis drug, Orkambi.
